Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    24168956 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Study of the Optimal Protocol for Methotrexate and Adalimumab Combination Therapy in Early Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Interventions: Biological: adalimumab;   Drug: methotrexate;   Biological: placebo

Indicates status has not been verified in more than two years